Pauza Charles David — SEC Form 4 filings

SEC reporting owner CIK 2018150. 5 Form 4 filings on record with FilingPulse; latest filed 2026-07-16.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2024-04-03 to 2026-07-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Traws Pharma, Inc. (TRAW)Chief Science Officer Virology58

Form 4 filings — Pauza Charles David

FiledFormIssuerReported transactionsSource
2026-07-164Traws Pharma, Inc. (TRAW)Grant/award (A): 97,000 (derivative) @ $0EDGAR
2026-03-104Traws Pharma, Inc. (TRAW)Grant/award (A): 118,367 (derivative) @ $0EDGAR
2025-12-164Traws Pharma, Inc. (TRAW)Grant/award (A): 18,471 @ $0 · Grant/award (A): 73,886 (derivative) @ $0EDGAR
2025-10-154Traws Pharma, Inc. (TRAW)Grant/award (A): 32,406 (derivative) @ $0EDGAR
2024-04-034Traws Pharma, Inc. (TRAW)Grant/award (A): 97,500 · Grant/award (A): 333,136 (derivative) · Grant/award (A): 503,227 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2018150 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →